Skip to content
DataLookout
Menu

NCT06677151

NPA-OSA Device Tolerability, Usability and Acclimation Clinical Study in Adult Obstructive Sleep Apnea (OSA) Patients

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved at least 11 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 6 versions: 4 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Oct 2026 to Oct 2027
    • Eligibility criteria expanded, about 20 words
    • Study completion pushed from Dec 2026 to Dec 2027
    • Site contacts updated at 2 of 2 sites
  2. Notable Primary completion date: Mar 2026 to Oct 2026
    • Study completion date: Mar 2026 to Dec 2026
    • Site contacts updated at 1 of 2 sites
    v5
  3. Notable Lead sponsor: [Redacted] to University of Michiganv4 Show 5 more changesShow less
    • Trial status: Withheld to Recruiting
    • Primary and study completion dates: Mar 2026
    • Start date: Mar 7, 2025
    • Collaborators expanded, about 7 words
    • Study title expanded, about 2 words
  4. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Change in severity of apnea hypopnea index (AHI)
Timeframe: Baseline (day 0), 30 days

Arms and interventions

Nasopharyngeal airway deviceExperimental

A nasopharyngeal airway obstructive sleep apnea ("NPA"-OSA) device will be used for one night in a sleep laboratory and 30 days at home.

Devices: nasopharyngeal airway obstructive sleep apnea (NPA-OSA) device

Sites

2 sites in 1 country